Ranbaxy forfeits 180 days exclusivity for stomach drugs
Drug major Ranbaxy on Tuesday said that the US health regulator has "determined" that the Indian drug manufacturer has forfeited its 180 days exclusivity for stomach and esophagus problems treatment tablets.
Jan 27, 2015, 13:16 PM IST